About

About ProMedix ProMedix Inc is a medical device spinout company from Oregon Health & Sciences University. Our fingertip, circulatory dysfunction monitoring device, “PeriFRL” saves thousands of lives by enabling physicians (through tracking minute changes in Capillary Refill Time - "CRT") to rapidly identify septic shock, and noninvasively monitor efficacy of therapeutic interventions once sepsis is diagnosed – all in real-time, and all at the patient bedside. The ProMedix PeriFRL commercialization glidepath includes connectivity and use of multivariable predictive algorithms. Current sepsis forecasting platforms lack physiologic input beyond simple vital signs and suffer from a high false-positive rate. Adding objective CRT measurement, a high-value patient-specific physiologic marker, to sepsis prediction algorithms will reduce the rate of false positive tests, making the risk prediction models more actionable than what is currently available. Including this patient-specific measurement can also address some of the pitfalls commonly associated with AI risk prediction model implementation. This set of customers is broad – from EHR companies (e.g., POC Advisor), to partnered data integration platforms (e.g., Validic). No one else has a serial-capable, stand-alone ability to monitor sepsis. There are several pathways into the marketplace. Optical detection of peripheral microcirculation facilitates early recognition of onset of sepsis; meeting calls from end-users for increased responsiveness and improve value-based care. Therefore, hospitals will be our initial focus for direct sales of our noninvasive PeriFRL monitor – with a primary emphasis on emergency room, intensive care, and med surg departments. Once ensconced, we will rapidly scale to partnering with either forecasting platform providers (as described above), or with targeted strategics (like Baxter and Medtronic; both of whom we are presently under NDA) to integrate our outputs into their existing patient monitoring telemetry portfolio (either via patient vitals, or in improved perfusion monitoring).